| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222 |
| filingDate |
2000-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_286abd0e649aa6e8b05348fab03b3109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b80cd20c5b3809789dda2aac73800b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e16676a77164ad4ada4fe3e2fe845c |
| publicationDate |
2003-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1200079-B1 |
| titleOfInvention |
2-aminotetralin derivatives for the therapy of glaucoma |
| abstract |
The use of racemic or optically active compounds represented by formula (I) and the salts thereof wherein R is H or CH<SUB>3 </SUB>for the preparation of pharmaceutical compositions for the therapy of ophthalmic disorders. |
| priorityDate |
1999-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |